Skip to main content
SpringerLink
Log in

NICE recommends nalmefene to reduce drinking . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE updated guidance recommends imatinib for digestive system cancers. Media Release : 26 Nov 2014. Available from: URL: http://www.nice.org.uk.

  2. NICE. NICE draft guidance recommends eculizumab (Soliris) for treating very rare life-threatening blood disorder. Media Release : 27 Nov 2014. Available from: URL: http://www.nice.org.uk.

  3. NICE. NICE recommends drug to help reduce high risk drinking. Media Release : 26 Nov 2014. Available from: URL: http://www.nice.org.uk.

  4. NICE. NICE set to recommend another leukaemia drug. Media Release : 2 Dec 2014. Available from: URL: http://www.nice.org.uk.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE recommends nalmefene to reduce drinking . . .. PharmacoEcon Outcomes News 717, 39 (2014). https://doi.org/10.1007/s40274-014-1764-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1764-4

Search

Navigation